When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Assessing An Investment In Myovant Sciences
Myovant Sciences Ltd.
I regard golf as an expensive way of playing marbles." - G.K. Chesterton
Being in London this week, I thought today, we would take an in-depth look at a local developmental firm in today's article.
Company Overview:
Myovant Sciences (MYOV) IPO'd in 2016 and is a United Kingdom-based healthcare company focused on becoming a key player in the space of women's health and prostate cancer. The company's lead product candidate is Relugolix, which is being developed to treat symptoms of uterine fibroids, symptoms of endometriosis, and advanced prostate cancer. The company's other